ArticleEye (London, England)2026
A 20-year review of orbital biopsy at the Newcastle Eye Centre.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Retinal microvascular alterations in sickle cell disease: a systematic review and meta-analysis of OCTA findings based on genotype and stages of retinopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo review the histopathological diagnoses, visual outcome, and complications of orbital biopsy in a UK tertiary referral centre.
methodsThis was a retrospective, clinico-pathological, interventional, consecutive case series. All orbital biopsies performed between January 2004 and December 2023 in Newcastle Eye Centre were included. Data collected from the local electronic database and medical records were analysed. The study was divided into Period 1 (2004-2013) and Period 2 (2014-2023) for descriptive and analytic purposes.
resultsA total of 338 orbital biopsies were identified during the study period: 180 patients (55.2%) were female and the mean age was 54.6 ± 20.2 years. Orbital biopsies were performed unilaterally in 314 (96.3%) patients and bilaterally in 12 (3.7%) patients. The two most common histopathological diagnoses were non-specific inflammatory disease (102, 31.3%) and lymphoma (85, 26.1%). Amongst cases classified as inflammatory disease, there was a significant increase in the IgG4 disease from Period 1 (2, 3.6%) to Period 2 (9, 15.8%; p = 0.029). The distribution of other diagnoses remained similar between the two periods. One patient (0.3%) experienced a ≥ 2 Snellen line drop in vision following biopsy. There were 14 (4.3%) patients with postoperative complications, the most common being diplopia (7, 2.1%). Postoperative diplopia was associated with posterior lesion (p = 0.045), lateral orbitotomy (p = 0.015) and excisional biopsy (p < 0.001).
conclusionThis study has not only shown orbital biopsy to be a safe an effective tool but also highlights an increase in IgG4 diagnosis. It has also identified significant risk factors for complication following orbital biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.